pyrimidin-2-one beta-ribofuranoside has been researched along with Neoplasms in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (64.29) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, X; Fang, H; Guo, Z; Hu, Y; Li, Y; Lin, L; Tian, H | 1 |
| Balkin, ER; Bryan, JN; Jia, F; Kumar, SR; Lewis, MR | 1 |
| Bonney, PL; Dhawan, D; Fourez, LM; Fulkerson, CM; Jones, DR; Jones, PA; Klaunig, JE; Knapp, DW; Marquez, VE; Wang, Z; Wu, Q | 1 |
| Butter, R; Linnekamp, JF; Medema, JP; Spijker, R; van Laarhoven, HWM | 1 |
| Issa, JP | 1 |
| Fu, L; Wang, XX | 1 |
| Farkas, DL; Gertych, A; Tajbakhsh, J | 1 |
| Hampton, T | 1 |
| Cheng, JC; Chuang, J; Greer, S; Jones, PA; Liang, G; Marquez, VE; Orntoft, TF; Thykjaer, T; Weisenberger, DJ; Wozniak, C; Yoo, CB | 1 |
| Bradbury, J | 1 |
| Cheng, JC; Jones, PA; Yoo, CB | 1 |
| Agbaria, R; Barchi, JJ; Ben-Kasus, T; Cheng, JC; Jones, PA; Kelley, JA; Marquez, VE; Rao, KV; Yoo, CB | 1 |
| Agbaria, R; Ben-Kasus, T; Cheng, JC; Jones, PA; Kelley, JA; Marquez, VE; Yoo, CB | 1 |
| Liu, H; Salford, LG; Sjögren, HO; Widegren, B; Xue, ZT | 1 |
5 review(s) available for pyrimidin-2-one beta-ribofuranoside and Neoplasms
| Article | Year |
|---|---|
Clinical and biological effects of demethylating agents on solid tumours - A systematic review.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Cytidine; Decitabine; DNA Methylation; Humans; Hydralazine; Immune System; Methylation; Neoplasms; Procaine; Treatment Outcome | 2017 |
[Recent advances in DNA demethylation in tumor therapy].
Topics: Animals; Cytidine; DNA Methylation; DNA Modification Methylases; Gene Knockout Techniques; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Neoplasms; RNA Interference; Valproic Acid | 2009 |
Zebularine: a new drug for epigenetic therapy.
Topics: Azacitidine; Cytidine; DNA Methylation; Epigenesis, Genetic; Genetic Therapy; Humans; Neoplasms; Pyrimidine Nucleosides | 2004 |
Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. The magic of its chemistry and biology.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cytidine; Cytidine Deaminase; DNA; Epigenesis, Genetic; Humans; Models, Chemical; Neoplasms | 2005 |
Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cytidine; Cytidine Deaminase; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Epigenesis, Genetic; Humans; Kinetics; Models, Chemical; Neoplasms | 2005 |
9 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and Neoplasms
| Article | Year |
|---|---|
Combination of epigenetic regulation with gene therapy-mediated immune checkpoint blockade induces anti-tumour effects and immune response in vivo.
Topics: Animals; B7-H1 Antigen; Cell Line, Tumor; Combined Modality Therapy; Cytidine; DNA Methylation; Epigenesis, Genetic; Genetic Therapy; Humans; Immune Checkpoint Inhibitors; Immunity; Immunotherapy; Methyltransferases; Neoplasm Metastasis; Neoplasms; T-Lymphocytes; Tumor Escape; Tumor Microenvironment | 2021 |
Zebularine significantly sensitises MEC1 cells to external irradiation and radiopharmaceutical therapy when administered sequentially in vitro.
Topics: Apoptosis; Cell Line, Tumor; Chemoradiotherapy; Cytidine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Humans; Neoplasms; Octreotide; Organometallic Compounds | 2014 |
Pharmacokinetics and toxicity of the novel oral demethylating agent zebularine in laboratory and tumor bearing dogs.
Topics: Administration, Oral; Aldehyde Oxidase; Animals; Chromatography, High Pressure Liquid; Cytidine; Cytosol; DNA Methylation; Dog Diseases; Dogs; Female; Half-Life; Indiana; Liver; Macrolides; Male; Neoplasms; Neutropenia; Schools, Veterinary | 2017 |
Cancer prevention: epigenetics steps up to the plate.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Transformation, Neoplastic; Chemoprevention; Cytidine; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Epigenesis, Genetic; Humans; Models, Biological; Neoplasms | 2008 |
Measuring topology of low-intensity DNA methylation sites for high-throughput assessment of epigenetic drug-induced effects in cancer cells.
Topics: Antineoplastic Agents; Azacitidine; Cell Line, Tumor; Cell Nucleus; Cytidine; Cytosine; DNA Methylation; DNA, Neoplasm; Epigenesis, Genetic; Fluorescence; High-Throughput Screening Assays; Humans; Indoles; Neoplasms; Nucleic Acid Conformation | 2010 |
Scientists probe shutting down cancer cells by awakening silenced genes.
Topics: Animals; Antineoplastic Agents; Cytidine; DNA Methylation; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Tumor Suppressor; Humans; Neoplasms; Pyrimidine Nucleosides | 2004 |
Preferential response of cancer cells to zebularine.
Topics: Antineoplastic Agents; Cell Division; Cell Line, Tumor; Cytidine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA, Neoplasm; Fibroblasts; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, p16; Humans; Neoplasms; Pyrimidine Nucleosides | 2004 |
Zebularine: a candidate for epigenetic cancer therapy.
Topics: Antineoplastic Agents; Cytidine; Epigenesis, Genetic; Humans; Neoplasms; Pyrimidine Nucleosides | 2004 |
Low dose Zebularine treatment enhances immunogenicity of tumor cells.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cytidine; Cytokines; DNA Methylation; Dose-Response Relationship, Drug; Immunosuppressive Agents; Male; Neoplasms; Rats; Reverse Transcriptase Polymerase Chain Reaction; Spleen; Transfection | 2007 |